Tag: pharmaceuticals
-
Bacterial-Biopolymer Delivery System Designed for Vaccines
A biotechnology company and university lab developed a vaccine delivery technique that induces an immune response, combining bacteria and a polymer material.
-
Hundreds of U.S. Clinics Found Selling Stem Cell Services
A comprehensive Internet search finds nearly 600 clinics in the U.S. claiming to offer stem cell treatments, many having dubious scientific or medical validity.
-
Protein Biotech Lands $51.5M in First Venture Round
A spin-off enterprise from Harvard developing therapies that block signaling proteins causing disease is raising $51.5 million its first venture funding round.
-
Radiation Enhances Nanoparticle Cancer Treatments
Targeting tumors with chemotherapy delivered in nanoparticles, preceded with radiation, was shown in lab mice to boost treatments in a range of cancers.
-
Moderna, Merck Partner on Personal Cancer Vaccines
29 June 2016. Biotechnology company Moderna Therapeutics and drug maker Merck are developing therapeutic vaccines using messenger RNA that address unique genetic patterns in patients’ tumors. The deal is expected to bring Moderna an immediate payment of $200 million, and the chance to earn further payments to develop cancer treatments combining Moderna’s technology with an…
-
Grant for Research on Drugs to Improve Tissue Transplants
27 June 2016. Department of Defense is funding research on new drugs that aim to improve the quality of tissue and limbs for transplants donated from people whose brains stop working. DoD awarded the grant of nearly $1 million to the Institute for Transformative Molecular Medicine at Case Western Reserve University School of Medicine in…
-
Genome Editing Company Adds $38M in Venture Funds
Crispr Therapeutics, a company creating treatments for disease that edit the human genome, is raising another $38 million in its second venture financing round.
-
Start-Up Developing Nanomedicines for Transplants
A spin-off enterprise from Medical University of South Carolina is creating drug delivery techniques that make it safer for patients needing organ transplants.
-
Celgene, Medical Centers to Partner on Cancer Therapies
Biopharmaceutical company Celgene Corp. and a consortium of four medical research institutes are collaborating on new diagnostics and treatments for cancer.
-
C. Difficile Infection Tested with Synthetic Gut Microbe
A biotechnology company reported on tests in mice of a synthetic treatment derived from gut microbes that prevents recurrence of C. difficile infections.